WeVote

Bill

Bill

HB 657

MEDICAL MARIJUANA: Provides relative to fees collected by the Louisiana Department of Health related to the sale of therapeutic marijuana (EN +$225,000 SG RV See Note)

2025 Regular Session Introduced by Neil Riser

Louisiana increases medical marijuana licensing fees by $225,000 annually to fund Department of Health regulatory operations, effective August 2025.

Becomes Act No. 513 without the Governor's signature.
0
WeVote Research Nonpartisan
Bill Summary · HB 657

Legislative bill overview

HB 657 adjusts the fee structure that the Louisiana Department of Health collects from medical marijuana sales. The bill generates approximately $225,000 in additional state general revenue through modified licensing or transaction fees related to therapeutic marijuana operations.

Why is this important

Medical marijuana programs rely on regulatory fees to fund oversight operations, testing, and compliance activities. Fee adjustments directly impact both the state's ability to fund program administration and the operational costs for licensed marijuana businesses, which can affect product pricing and market access for patients.

Potential points of contention

  • Business cost burden: Increased fees may be passed to consumers or reduce profit margins for licensed producers and retailers
  • Program funding adequacy: Whether the $225,000 increase is sufficient for robust regulatory oversight or represents overcharging relative to actual administrative costs
  • Competitive impact: Fee structures that disproportionately burden smaller operators versus larger corporations could consolidate market power

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.